000848187 001__ 848187
000848187 005__ 20210129234017.0
000848187 0247_ $$2doi$$a10.1007/s11307-018-1221-z
000848187 0247_ $$2ISSN$$a1536-1632
000848187 0247_ $$2ISSN$$a1860-2002
000848187 0247_ $$2pmid$$apmid:29845426
000848187 0247_ $$2WOS$$aWOS:000458989800019
000848187 0247_ $$2Handle$$a2128/23185
000848187 0247_ $$2altmetric$$aaltmetric:55988816
000848187 037__ $$aFZJ-2018-03453
000848187 082__ $$a610
000848187 1001_ $$0P:(DE-Juel1)156479$$aStegmayr, Carina$$b0
000848187 245__ $$aInfluence of Dexamethasone on O-(2-[18F]-Fluoroethyl)-l-Tyrosine Uptake in the Human Brain and Quantification of Tumor Uptake
000848187 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2019
000848187 3367_ $$2DRIVER$$aarticle
000848187 3367_ $$2DataCite$$aOutput Types/Journal article
000848187 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1550838220_4116
000848187 3367_ $$2BibTeX$$aARTICLE
000848187 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000848187 3367_ $$00$$2EndNote$$aJournal Article
000848187 520__ $$aPurposeO-(2-[18F]fluoroethyl)-l-tyrosine ([18F]FET) is an established positron emission tomography (PET) tracer for brain tumor imaging. This study explores the influence of dexamethasone therapy on [18F]FET uptake in the normal brain and its influence on the maximum and mean tumor-to-brain ratio (TBR).Procedures[18F]FET PET scans of 160 brain tumor patients were evaluated (80 dexamethasone treated, 80 untreated; each group with 40 men/40 women). The standardized uptake value of [18F]FET uptake in the normal brain (SUVbrain) in the different groups was compared. Nine patients were examined repeatedly with and without dexamethasone therapy.ResultsSUVbrain of [18F]FET uptake was significantly higher in dexamethasone-treated patients than in untreated patients (SUVbrain 1.33 ± 0.1 versus 1.06 ± 0.16 in male and 1.45 ± 0.25 versus 1.31 ± 0.28 in female patients). Similar results were observed in patients with serial PET scans. Furthermore, compared to men, a significantly higher SUVbrain was found in women, both with and without dexamethasone treatment. There were no significant differences between the different groups for TBRmax and TBRmean, which could have been masked by the high standard deviation. In a patient with a stable brain metastasis investigated twice with and without dexamethasone, the TBRmax and the biological tumor volume (BTV) decreased considerably after dexamethasone due to an increased SUVbrain.ConclusionDexamethasone treatment appears to increase the [18F]FET uptake in the normal brain. An effect on TBRmax, TBRmean, and BTV cannot be excluded which should be considered especially for treatment monitoring and the estimation of BTV using [18F]FET PET.
000848187 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000848187 588__ $$aDataset connected to CrossRef
000848187 7001_ $$0P:(DE-Juel1)131627$$aStoffels, Gabriele$$b1
000848187 7001_ $$0P:(DE-Juel1)131788$$aRota Kops, Elena$$b2
000848187 7001_ $$0P:(DE-Juel1)145110$$aLohmann, Philipp$$b3
000848187 7001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b4
000848187 7001_ $$0P:(DE-Juel1)131794$$aShah, Nadim J.$$b5
000848187 7001_ $$0P:(DE-Juel1)166419$$aNeumaier, Bernd$$b6
000848187 7001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b7$$eCorresponding author
000848187 773__ $$0PERI:(DE-600)2079211-6$$a10.1007/s11307-018-1221-z$$n1$$p168–174$$tMolecular imaging & biology$$v21$$x1860-2002$$y2019
000848187 8564_ $$uhttps://juser.fz-juelich.de/record/848187/files/Stegmayr2019_Article_InfLuenceOfDexamethasoneOnO-2-.pdf$$yRestricted
000848187 8564_ $$uhttps://juser.fz-juelich.de/record/848187/files/Stegmayr2019_Article_InfLuenceOfDexamethasoneOnO-2-.pdf?subformat=pdfa$$xpdfa$$yRestricted
000848187 8564_ $$uhttps://juser.fz-juelich.de/record/848187/files/Stegmayr_2019_Post%20Print_%20Mol%20Imaging%20Biol_Influence%20of%20Dexamethasone%20on%20O-%282-18F-Fluoroethyl%29-L-Tyrosine%20Uptake.pdf$$yOpenAccess
000848187 8564_ $$uhttps://juser.fz-juelich.de/record/848187/files/Stegmayr_2019_Post%20Print_%20Mol%20Imaging%20Biol_Influence%20of%20Dexamethasone%20on%20O-%282-18F-Fluoroethyl%29-L-Tyrosine%20Uptake.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000848187 909CO $$ooai:juser.fz-juelich.de:848187$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000848187 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)156479$$aForschungszentrum Jülich$$b0$$kFZJ
000848187 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131627$$aForschungszentrum Jülich$$b1$$kFZJ
000848187 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131788$$aForschungszentrum Jülich$$b2$$kFZJ
000848187 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145110$$aForschungszentrum Jülich$$b3$$kFZJ
000848187 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b4$$kFZJ
000848187 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131794$$aForschungszentrum Jülich$$b5$$kFZJ
000848187 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166419$$aForschungszentrum Jülich$$b6$$kFZJ
000848187 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b7$$kFZJ
000848187 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000848187 9141_ $$y2019
000848187 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000848187 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000848187 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMOL IMAGING BIOL : 2015
000848187 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000848187 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000848187 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000848187 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000848187 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000848187 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000848187 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000848187 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000848187 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000848187 920__ $$lyes
000848187 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000848187 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x1
000848187 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x2
000848187 9201_ $$0I:(DE-Juel1)INM-11-20170113$$kINM-11$$lJara-Institut Quantum Information$$x3
000848187 980__ $$ajournal
000848187 980__ $$aVDB
000848187 980__ $$aUNRESTRICTED
000848187 980__ $$aI:(DE-Juel1)INM-3-20090406
000848187 980__ $$aI:(DE-Juel1)INM-4-20090406
000848187 980__ $$aI:(DE-Juel1)INM-5-20090406
000848187 980__ $$aI:(DE-Juel1)INM-11-20170113
000848187 9801_ $$aFullTexts